PE20181178A1 - Compuestos carbocilicos novedosos como moduladores de ror gamma - Google Patents
Compuestos carbocilicos novedosos como moduladores de ror gammaInfo
- Publication number
- PE20181178A1 PE20181178A1 PE2018000317A PE2018000317A PE20181178A1 PE 20181178 A1 PE20181178 A1 PE 20181178A1 PE 2018000317 A PE2018000317 A PE 2018000317A PE 2018000317 A PE2018000317 A PE 2018000317A PE 20181178 A1 PE20181178 A1 PE 20181178A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- compounds
- haloalkyl
- hydroxyl
- carbocylic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Referido a compuestos carbociclicos de formula (I), en donde R1 es amino, hidroxilo, alquilo C1-8 y alcoxi C1-8; R2 es alquilo C1-8, haloalquilo C1-8, hidroxialquilo C1-8, entre otros; R3 es hidrogeno, alquilo C1-8, haloalquilo C1-8, entre otros; R4 es alquilo C1-8, alcoxi C1-8, haloalquilo C1-8, entre otros; R5 es halogeno, hidroxilo, ciano, alquilo C1-8, entre otros; R6 es halogeno, ciano, hidroxilo, alquilo C1-8 y cicloalquilo C3-6; cada uno de Ra y Rb son, independientemente, hidrogeno, alquilo C1-8; o juntos pueden formar un oxo; n es 1, 2, 3 o 4; m es 0, 1 o 2; y p es 0 o 1. Dichos compuestos son moduladores del receptor huerfano gamma t vinculado a retinoides (RORyt), siendo utiles para el tratamiento de enfermedades, trastornos, sindromes o afecciones mediados por RORyt, tales como dolor, inflamacion, EPOC, asma, artritis reumatoide, colitis, esclerosis multiple, psoriasis, enfermedades neurodegenerativas y cancer
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3299MU2015 | 2015-08-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20181178A1 true PE20181178A1 (es) | 2018-07-20 |
Family
ID=58186928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2018000317A PE20181178A1 (es) | 2015-08-28 | 2016-08-26 | Compuestos carbocilicos novedosos como moduladores de ror gamma |
Country Status (16)
Country | Link |
---|---|
US (2) | US10189775B2 (es) |
EP (1) | EP3341357A4 (es) |
JP (1) | JP2018526372A (es) |
KR (1) | KR20180044384A (es) |
CN (1) | CN108026039A (es) |
AU (1) | AU2016314547A1 (es) |
CA (1) | CA2996017A1 (es) |
CL (1) | CL2018000504A1 (es) |
EA (1) | EA201890330A1 (es) |
HK (1) | HK1257756A1 (es) |
IL (1) | IL257525A (es) |
MX (1) | MX2018002478A (es) |
PE (1) | PE20181178A1 (es) |
PH (1) | PH12018500411A1 (es) |
WO (1) | WO2017037595A1 (es) |
ZA (1) | ZA201801268B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018042342A1 (en) * | 2016-08-30 | 2018-03-08 | Glenmark Pharmaceuticals S.A. | 1,2,3-benzotriazole derivatives as ror gamma t modulators |
WO2018193297A1 (en) | 2017-04-21 | 2018-10-25 | Cadila Healthcare Limited | Novel compounds as ror-gamma modulators |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6174905B1 (en) * | 1996-09-30 | 2001-01-16 | Mitsui Chemicals, Inc. | Cell differentiation inducer |
JP2002179651A (ja) * | 1998-06-19 | 2002-06-26 | Wakamoto Pharmaceut Co Ltd | ベンズアニリド誘導体及び医薬組成物 |
DE10306250A1 (de) * | 2003-02-14 | 2004-09-09 | Aventis Pharma Deutschland Gmbh | Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
US8501982B2 (en) * | 2010-06-09 | 2013-08-06 | Receptos, Inc. | GLP-1 receptor stabilizers and modulators |
WO2012027965A1 (en) | 2010-09-01 | 2012-03-08 | Glaxo Group Limited | Novel compounds |
WO2012028100A1 (en) | 2010-09-01 | 2012-03-08 | Glaxo Group Limited | Novel compounds |
US8772562B2 (en) | 2010-11-10 | 2014-07-08 | Exxonmobil Research And Engineering Company | Process for making basestocks from renewable feedstocks |
WO2012100732A1 (en) | 2011-01-24 | 2012-08-02 | Glaxo Group Limited | Retinoid-related orphan receptor gamma modulators, composition containing them and uses thereof |
WO2012100734A1 (en) | 2011-01-24 | 2012-08-02 | Glaxo Group Limited | Compounds useful as retinoid-related orphan receptor gamma modulators |
EP2511263A1 (en) | 2011-04-14 | 2012-10-17 | Phenex Pharmaceuticals AG | Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases |
WO2013171729A2 (en) | 2013-01-08 | 2013-11-21 | Glenmark Pharmaceuticals S.A. | Aryl and heteroaryl amide compounds as rorgamat modulator |
WO2015008234A1 (en) | 2013-07-17 | 2015-01-22 | Glenmark Pharmaceuticals S.A. | Bicyclic heterocyclic compounds as ror gamma modulators |
-
2016
- 2016-08-26 CA CA2996017A patent/CA2996017A1/en not_active Abandoned
- 2016-08-26 CN CN201680056214.8A patent/CN108026039A/zh active Pending
- 2016-08-26 WO PCT/IB2016/055104 patent/WO2017037595A1/en active Application Filing
- 2016-08-26 US US15/754,037 patent/US10189775B2/en not_active Expired - Fee Related
- 2016-08-26 AU AU2016314547A patent/AU2016314547A1/en not_active Abandoned
- 2016-08-26 KR KR1020187008486A patent/KR20180044384A/ko unknown
- 2016-08-26 PE PE2018000317A patent/PE20181178A1/es unknown
- 2016-08-26 EP EP16840923.3A patent/EP3341357A4/en not_active Withdrawn
- 2016-08-26 MX MX2018002478A patent/MX2018002478A/es unknown
- 2016-08-26 JP JP2018511012A patent/JP2018526372A/ja active Pending
- 2016-08-26 EA EA201890330A patent/EA201890330A1/ru unknown
-
2018
- 2018-02-14 IL IL257525A patent/IL257525A/en unknown
- 2018-02-23 ZA ZA2018/01268A patent/ZA201801268B/en unknown
- 2018-02-23 PH PH12018500411A patent/PH12018500411A1/en unknown
- 2018-02-26 CL CL2018000504A patent/CL2018000504A1/es unknown
- 2018-11-29 US US16/204,977 patent/US10336688B2/en not_active Expired - Fee Related
-
2019
- 2019-01-04 HK HK19100131.9A patent/HK1257756A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP3341357A1 (en) | 2018-07-04 |
US20180237382A1 (en) | 2018-08-23 |
WO2017037595A1 (en) | 2017-03-09 |
JP2018526372A (ja) | 2018-09-13 |
CN108026039A (zh) | 2018-05-11 |
KR20180044384A (ko) | 2018-05-02 |
HK1257756A1 (zh) | 2019-10-25 |
US20190144375A1 (en) | 2019-05-16 |
ZA201801268B (en) | 2019-05-29 |
CL2018000504A1 (es) | 2018-07-06 |
MX2018002478A (es) | 2018-06-15 |
CA2996017A1 (en) | 2017-03-09 |
US10336688B2 (en) | 2019-07-02 |
IL257525A (en) | 2018-04-30 |
EA201890330A1 (ru) | 2018-07-31 |
PH12018500411A1 (en) | 2018-08-29 |
EP3341357A4 (en) | 2019-03-27 |
US10189775B2 (en) | 2019-01-29 |
AU2016314547A1 (en) | 2018-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2018000289A1 (es) | Compuestos nuevos como moduladores de ror gamma. | |
PH12016502045A1 (en) | Aryl and heteroaryl ether compounds as ror gamma modulators | |
PE20161572A1 (es) | Compuestos como moduladores de ror gamma | |
ECSP17047155A (es) | Productos farmacéuticos y composiciones líquidas estables de anticuerpos contra il-17 | |
CL2015000300A1 (es) | Compuestos derivados de pirroles y pirazoles sustituidos, moduladores del receptor nuclear huerfano ror gamma; composicion farmaceutica; uso en el tratamiento o profilaxis de enfermedades del sistema inmunitario tales como artritis reumatoide, lupus eritematoso, esclerosis multiple, epoc, entre otras. | |
ECSP16061758A (es) | Moduladores de tetrahidropiridopirazinas de gpr6 | |
CL2016001579A1 (es) | Nuevas indazolcarboxamidas, procedimientos para su preparación, preparaciones farmacéuticas que las contienen, así como su uso para la preparación de medicamentos. | |
CL2015002655A1 (es) | Moduladores de p2x7 | |
CR20140493A (es) | Compuestos novedosos | |
CL2015002125A1 (es) | Moduladores de receptores nmda de espiro-lactama y sus usos. | |
UY36037A (es) | Derivados de indazol y 2-metil-pirazol-piridina sustituidos como inhibidores de la tirosina quinasa (syk) del bazo y composiciones farmacéuticas que las contienen | |
PE20160687A1 (es) | Analogos de heteroaril indol biciclico utiles como moduladores de ror | |
CL2017002799A1 (es) | Sulfonas triciclicas como moduladores del receptor huérfano relacionado con retinoide gamma (rory) | |
PE20160716A1 (es) | Anticuerpo anti-tweakr y sus usos | |
DOP2018000008A (es) | Inhibidores del receptor del factor estimulador de colonias 1 (csf-1r) | |
ECSP20061469A (es) | Anticuerpos Anti-Trem-1 y Usos de los Mismos | |
DOP2016000311A (es) | Nuevos compuestos | |
CL2015001495A1 (es) | Compuestos benzofusionados sustituidos, moduladores selectivos del receptor de andrógenos y sus usos en el tratamiento de enfermedades tales como anorexia, anemia, artritis, entre otras. | |
CL2017002405A1 (es) | Compuestos bicíclicos fusionados, composición farmacéutica que los comprende y su uso para el tratamiento de enfermedades o desordenes relacionados con el fxr. | |
PE20181178A1 (es) | Compuestos carbocilicos novedosos como moduladores de ror gamma | |
ECSP16074207A (es) | Pirazinas moduladoras de gpr6 | |
CL2016002321A1 (es) | Compuestos derivados del ácido 2-8-5-cloropirimidin-2-ilamino-6,7,8,9-tetrahidro-5h-pirido3,2-bindol-5-ilacético, moduladores del receptor de prostaglandina d2 composición farmacéutica y su uso para el tratamiento de enfermedadestrastornos alérgicosinmunitarios. | |
BR112017015912A2 (pt) | reator de leito inclinado que permite utilizar uma pequena quantidade de catalisador | |
CR20190096A (es) | Análogos de insulina | |
CL2017001231A1 (es) | Espiro-tiazolonas |